Prostate-specific antigen after anatomic radical retropubic prostatectomy: Patterns of recurrence and cancer control

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 395-406

  Pound, C R ^a   Partin, A W ^a   Epstein, J I ^a   Walsh, P C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER STAGING; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SEMINAL VESICLE; SEXUAL FUNCTION; SURVIVAL RATE; TRANSURETHRAL RESECTION; TREATMENT FAILURE;

EID: 0030963436     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70386-4     Document Type: Article

References (19)

1. W.J. Catalona D.J. Smith Five-year tumor recurrence rates after anatomic radical retropubic prostatectomy for prostate cancer J Urol 152 1994 1837 1842
2. G.W. Chodak R.A. Thisted G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242 248
3. J.I. Epstein G. Pizov P.C. Walsh Correlation of pathologic findings with progression following radical retropubic prostatectomy Cancer 71 1993 3582 3593
4. J.I. Epstein M.J. Carmichael G. Pizov Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term follow-up J Urol 150 1993 135 141
5. J.I. Epstein A.W. Partin J. Sauvageot Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up Am J Surg Pathol 20 1996 286 292
6. J.E. Johansson H.O. Adami S.O. Andersson High 10-year survival rate in patients with early, untreated prostatic cancer JAMA 267 1992 2191 2196
7. G.W. Jones Prospective, conservative management of localized prostate cancer Cancer 70 suppl 1992 307 310
8. B. Moskowitz S. Nitecki L.D. Richter Cancer of the prostate: Is there a need for aggressive treatment? Urol Int 42 1987 49
9. M.G. Oefelein N. Smith M. Carter The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies J Urol 154 1995 2128 2131
10. J. Oesterling Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 145 1991 907
11. M. Ohori J.R. Goad T.M. Wheeler Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 154 1995 1818 1824
12. A. Partin C. Pound J. Clemons Serum PSA after anatomic radical prostatectomy: The Johns Hopkins Experience after 10 years Urol Clin North Am 20 1993 713
13. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747 752
14. A.W. Partin J.D. Pearson P.K. Landis Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology 43 1994 649 659
15. F.H. Schroder P. Hermanek L. Denis The TNM classification of prostate cancer Prostate 4 suppl 1992 129 138
16. J.G. Trapasso J.B. DeKernion R.B. Smith The incidence and significance of detectable levels of serum PSA after radical prostatectomy J Urol 152 1994 1821 1825
17. P.C. Walsh The natural history of localized prostate cancer: A guide to therapy Cambell's Urology ed 6 1995 WB Saunders Philadelphia 4 update 13
18. W.F. Whitmore Jr J.A. Warner I.M. Thompson Jr Expectant management of localized prostatic cancer Cancer 67 1991 1091 1096
19. H. Zincke J.E. Oesterling M.L. Blute Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850 1857